Trade BioNTech ^BNTX

BioNTech (NASDAQ:BNTX) Stock: Insider Ugur Sahin Sells 27,000 Shares

BioNTech (NASDAQ:BNTX) Stock: Insider Ugur Sahin Sells 34,000 Shares

How New Lung Cancer Data And Updated COVID Shot At BioNTech (BNTX) Has Changed Its Investment Story

Analysts Conflicted on These Healthcare Names: Harmony Biosciences Holdings (HRMY), BioNTech SE (BNTX) and Biogen (BIIB)

BioNTech (NasdaqGS:BNTX) Stock May Look Fully Valued On Fresh Lung Cancer Trial Data

BioNTech co-founders name new pharmaceutical company 'Arife' - Türkiye News

BioNTech (NASDAQ:BNTX) Stock: Insider Ugur Sahin Sells 30,000 Shares

Could a New Vaccine Formula XFG Give Pfizer (PFE) and BioNTech (BNTX) a Post-Pandemic Revenue Boost?

BioNTech (NASDAQ:BNTX) Stock: Insider Ugur Sahin Sells 39,000 Shares - Stock Observer

BioNTech (NASDAQ:BNTX) CEO Sells 46,000 Shares of Stock

Insider Selling: BioNTech (NASDAQ:BNTX) CEO Sells $4,633,120.00 in Stock - Zolmax

BioNTech (NASDAQ:BNTX) CEO Sells 33,000 Shares

Moderna Adds Another 5% and Is Up 500% in 2026. Can MRNA Stock Continue the Melt-Up?

Biontech Se (BNTX) - Insider Monkey

Moderna Surges 9% as Phase 3 Melanoma Data Wins Presidential Symposium Slot; Merck and BioNTech Edge Higher

BioNTech (BNTX) Could Be 19% Undervalued On Vaccine Approval And Phase 3 Data

Ugur Sahin Sells 34,000 Shares of BioNTech (NASDAQ:BNTX) Stock

BioNTech (NASDAQ:BNTX) CEO Ugur Sahin Sells 30,000 Shares - Daily Political

Did Survival Trial Win Just Shift BioNTech (BNTX) Investment Narrative?

Is BioNTech (BNTX) Too Pricey for Its Current Sales Base?

BioNTech (NASDAQ:BNTX) CEO Sells $3,280,660.00 in Stock

Ugur Sahin Sells 15,000 Shares of BioNTech (NASDAQ:BNTX) Stock

BioNTech (NASDAQ:BNTX) CEO Sells 34,000 Shares of Stock - Stock Observer

BioNTech's Lung Cancer Drug Shows Signs of a Major Breakthrough

BioNTech and OncoC4 report median OS data from RESERVE-003 Phase III trial

Brokerages Set BioNTech SE Sponsored ADR (NASDAQ:BNTX) Target Price at $127.44 - Zolmax

Insider Selling: BioNTech (NASDAQ:BNTX) CEO Sells $4,361,850.00 in Stock

BioNTech (NASDAQ:BNTX) CEO Ugur Sahin Sells 41,000 Shares of Stock - Stock Observer

BioNTech (NASDAQ:BNTX) Shares Gap Up - What's Next?

BioNTech lung cancer drug extends survival versus chemotherapy

BioNTech's Gotistobart Nearly Doubles Median Overall Survival In Previously Treated Squamous NSCLC

Analysts Set BioNTech SE Sponsored ADR (NASDAQ:BNTX) PT at $127.44 - Daily Political

Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat

Analysts Set BioNTech SE Sponsored ADR (NASDAQ:BNTX) Target Price at $127.44 - Markets Daily

Insider Selling: BioNTech (NASDAQ:BNTX) CEO Sells 36,000 Shares of Stock - Markets Daily

BioNTech (NASDAQ:BNTX) CEO Ugur Sahin Sells 37,000 Shares

BioNTech (NASDAQ:BNTX) CEO Sells $3,520,080.00 in Stock - Stock Observer

New MUC16-targeting ADC reported in Biontech patent

BioNTech SE Sponsored ADR $BNTX Shares Sold by Carmignac Gestion

Ugur Sahin Sells 31,500 Shares of BioNTech (NASDAQ:BNTX) Stock - Zolmax

Insider Selling: BioNTech (NASDAQ:BNTX) CEO Sells 31,500 Shares of Stock - Markets Daily

Carmignac Gestion Has $7.45 Million Stake in BioNTech SE Sponsored ADR $BNTX - Daily Political

BMO lowers Amgen, BioNTech to Market Perform as risk-reward shifts

BioNTech Shares Fall After BMO Downgrade and Price Target Cut

Swapped Lives: The 15-Year Fork in the Road Between Moderna and BioNTech

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

Unlocking Opportunity: Dominate the Cancer Vaccine Market with Confidence Now Available. Tracks 960+ Organizations and 2,100+ Drugs Across the Full Cancer Vaccine Pipeline

BioNTech's Promising Oncology Pipeline Is Now in Late-Stage Development | Morningstar

This $26 Billion Biotech Name Is Ripe for a Covered-Call Trade

Pfizer (PFE) Stock Looks Overvalued After Updated COVID Vaccine Approval

BioNTech (BNTX) Stock Looks Above Fair Value As Shares Fell 70%

BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now?

Is BioNTech Stock a No-Brainer Buy on the Dip?

BioNTech (BNTX) Halts Cancer Trial, Is The 15% Undervaluation Still Credible?

Pfizer (PFE) Following FDA Vaccine Approval Has Fair Value Back In Focus

BioNTech (NASDAQ:BNTX) Given New $136.00 Price Target at Canaccord Genuity Group - Markets Daily

Pfizer Inc. (NYSE:PFE) Receives $28.28 Consensus Target Price from Analysts - Markets Daily

Canaccord Genuity Group Cuts BioNTech (NASDAQ:BNTX) Price Target to $136.00 - Stock Observer

Headlands Technologies LLC Takes Position in BioNTech SE Sponsored ADR $BNTX - Daily Political

Investors Purchase High Volume of BioNTech Put Options (NASDAQ:BNTX)

USD/CAD Forecast 2026–2030: Can Fed–BoC Rate Divergence Push the Pair Above 1.42?

PCE+GDP: A Double Data Shock Could Move Markets

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Is SpaceX a Good Stock to Buy in 2026?

Best Gold Stock to Buy Now: 6 Gold Stocks to Watch in 2026

Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?

Gold Price Trend 2024-2026: From $2,000 to Record Highs, What Comes Next?

Upcoming IPOs 2026: The Biggest Companies to Watch and Major Listings So Far

Moderna Stock Soars 177% as Cancer Vaccine Delivers a Landmark Phase 3 Win

AMD Stock Falls 3.6% as Oil and Treasury Yields Rise; $8.2 Billion World Labs Deal Announced After Close

US Stocks Fall as Dow Drops 347 Points; Chip Shares Slide Despite Nvidia Buyback

Nvidia Stock Rises as Record $150 Billion Buyback Defies Chip Selloff

Gold Price Today: Spot Gold Edges Higher Near $4,116 After Monday’s Sharp Selloff

Bitcoin Price Falls Below $83,000 as Futures Open Interest Nears 2026 Lows

Micron Earnings Preview: Can AI Memory Demand Lift Q4 Results Above High Expectations?

Gold Price Today: Spot Gold Slides Toward $4,200 as Fed Rate Outlook Weighs

Oil Price Today: Brent Rises Above $105 as US–Iran Talks Stall